Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
about
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazoleTherapeutic Approach to Adult Fibrotic Lung DiseasesCoupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT ProlongationChanges in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011The association between gastroesophageal reflux disease and recurrent respiratory papillomatosis: A systematic review.Big data analytics to improve cardiovascular care: promise and challenges.Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.Analysis of Changes in Parathyroid Hormone and 25 (OH) Vitamin D Levels with Respect to Age, Gender and Season: A Data Mining Study.Androgen Deprivation Therapy and Future Alzheimer's Disease RiskTherapy: Risks associated with chronic PPI use - signal or noise?Proton pump inhibitors: Risks of long-term use.Proton pump inhibitors and vascular function: A prospective cross-over pilot studyThe Indications, Applications, and Risks of Proton Pump InhibitorsProton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.Proton Pump Inhibitors and the Risk of Osseointegrated Dental Implant Failure: A Cohort Study.Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.Risk of acute myocardial infarction in patients with gastroesophageal reflux disease: A nationwide population-based studyImpact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndromeIndividual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic ReviewAsymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.How May Proton Pump Inhibitors Impair Cardiovascular Health?Proton Pump Inhibitors Accelerate Endothelial SenescenceIdiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results.Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's HospitalsOmeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction.Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist.The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.Serum magnesium and risk of new onset heart failure in men: the Kuopio Ischemic Heart Disease Study.The influence of proton pump inhibitors and other commonly used medication on the gut microbiota.Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability.A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux.Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.No Association of Proton Pump Inhibitor Use with Fasting or Postload Glycaemia in Patients with Cardiovascular Disease: A Cross-Sectional Retrospective Study.Can Endothelial Injury Provide the Passage to Explain the Vascular Effects of Proton Pump Inhibitors?
P2860
Q26741015-ADB2DB9C-C467-4781-9BCA-6AA947FB6B66Q26741569-FF022EE8-88AB-4386-A353-5EF48E81552DQ27231482-843EF986-9524-4D96-B7A8-5E9D93DB0383Q28109335-BA97DEEA-C682-4934-8B4D-EE1BAB32A5F4Q30251514-5952BCF3-ED77-46CA-B80C-FC87E0887EE8Q31062479-F7F082F6-7557-48E7-B079-91F007551596Q31157434-283434F3-FCFC-4E96-853A-11C6E374E724Q33441225-88DF2918-1CAB-4F37-B744-1CE01A870FB9Q33801130-867EB33D-E5EE-45D0-BF18-2FC45388D521Q34504328-632FD9E9-A124-4F83-A0A4-9DA3E3D7AE0AQ34519455-2B7F5D22-6E71-435B-83B1-210A570AD0B9Q34549406-1FCA0F17-CAEE-45CF-8AA2-9825438399C5Q36067712-82CB5959-D90E-456E-A805-65DA48EB62BEQ36091187-7A4F140E-99EC-4D02-B6D8-5140413DCD95Q36117874-6D44CCE8-00A7-4CA6-8B51-5612DD91AEFDQ36170237-36B96E0E-D65A-4D0B-AF07-3C9B4C3A3F85Q36281192-937DE098-EF9D-4D71-B9FF-1E1566E848D5Q36314770-32D2937F-A01E-4C8A-ACB1-C0E46E4829E6Q36784692-0762E7CE-19B4-405D-9998-A5FEF492A134Q36836236-24D44779-0C39-420A-BF89-25E2B81CA2F5Q36846899-ADADB747-40C2-452B-9583-6B9F2DBA532BQ36892867-ECE9B6D4-A0B9-42EC-96A7-357E7E28698BQ36993998-7C87CB3E-3537-4FC7-A6B3-2FE1233ECA7FQ37013159-F05E9232-5AF8-441B-9C01-3C3BA496F9CEQ37017659-29483A84-2560-42EB-8C9E-BA07508ADBCBQ37047798-5646BACF-D61B-4DFD-9D3A-52F0D4FEE4EBQ37171592-9FD56E3E-0257-4146-BDB7-B22BFE47CA92Q37532133-04F5047A-F6BC-4D54-B428-B95943B0F587Q37709906-620AA074-3369-4E89-880C-E3A1CF109A7EQ38617406-AADA314A-FBF2-46F5-811B-234402085576Q38646393-9CE6C132-E78D-4746-B420-2DEA9D054CA0Q38668590-95E51CB8-3888-4921-B8DE-4F3925A54602Q38862988-CC3E0E84-6E38-4043-AD97-24A81D49C8C6Q39001908-5DD47F2D-EF86-42A6-BD7D-B0B8E6727A60Q39523340-C91E4866-9A8A-4930-92A8-902B9F559ABBQ39879045-06EC1B6A-B74D-47EA-A982-2F9A33ABF76FQ40053716-B2264A6D-1400-4C0A-B084-0EC6BF9886ADQ40248473-0C15BB5C-210A-43FA-A732-1E51AF6AAD62Q41035418-A0925DD3-21C9-4F14-BA04-393D0EA52C0AQ42333495-29F02883-0075-40AC-AC65-0D9C7FF6FA7B
P2860
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Proton Pump Inhibitor Usage an ...... tion in the General Population
@ast
Proton Pump Inhibitor Usage an ...... tion in the General Population
@en
Proton Pump Inhibitor Usage an ...... tion in the General Population
@nl
type
label
Proton Pump Inhibitor Usage an ...... tion in the General Population
@ast
Proton Pump Inhibitor Usage an ...... tion in the General Population
@en
Proton Pump Inhibitor Usage an ...... tion in the General Population
@nl
prefLabel
Proton Pump Inhibitor Usage an ...... tion in the General Population
@ast
Proton Pump Inhibitor Usage an ...... tion in the General Population
@en
Proton Pump Inhibitor Usage an ...... tion in the General Population
@nl
P2093
P2860
P3181
P1433
P1476
Proton Pump Inhibitor Usage an ...... tion in the General Population
@en
P2093
Anna Bauer-Mehren
Jake Marcus
Kevin T Nead
Nicholas J Leeper
Nigam H Shah
Paea LePendu
Srinivasan V Iyer
Yohannes T Ghebremariam
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0124653
P407
P577
2015-01-01T00:00:00Z